Cargando…
Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapy
The host immune system adopts multiple mechanisms involving antibodies to confront cancer cells. Accordingly, anti-tumor mAbs have become mainstays in cancer treatment. However, neither host immunity nor mAb therapies appear capable of controlling tumor growth in all cases. Structural instability of...
Autores principales: | Jordan, Robert E., Fan, Xuejun, Salazar, Georgina, Zhang, Ningyan, An, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140550/ https://www.ncbi.nlm.nih.gov/pubmed/30228951 http://dx.doi.org/10.1080/2162402X.2018.1480300 |
Ejemplares similares
-
IgGs drive COVID-19 myeloid hyperinflammation
por: Park, Matthew D.
Publicado: (2020) -
Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions
por: Fan, Xuejun, et al.
Publicado: (2022) -
Anti-amyloidogenic Activity of IgGs Contained in Normal Plasma
por: O’Nuallain, Brian, et al.
Publicado: (2010) -
Production of antigen-specific human IgGs by in vitro immunization
por: Wijkhuisen, A., et al.
Publicado: (2016) -
Glycomic Signatures on Serum IgGs for Prediction of Postvaccination Response
por: Wang, Jing-Rong, et al.
Publicado: (2015)